| A synthetic aptamer-drug adduct for targeted liver cancer therapy TL Trinh, G Zhu, X Xiao, W Puszyk, K Sefah, Q Wu, W Tan, C Liu PLoS One 10 (11), e0136673, 2015 | 96 | 2015 |
| Connective tissue growth factor and integrin αvβ6: a new pair of regulators critical for ductular reaction and biliary fibrosis in mice L Pi, PM Robinson, M Jorgensen, SH Oh, AR Brown, PH Weinreb, ... Hepatology 61 (2), 678-691, 2015 | 89 | 2015 |
| Aptamers against cells overexpressing glypican 3 from expanded genetic systems combined with cell engineering and laboratory evolution L Zhang, Z Yang, T Le Trinh, IT Teng, S Wang, KM Bradley, S Hoshika, ... Angewandte Chemie 128 (40), 12560-12563, 2016 | 78 | 2016 |
| S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes P Cheng, EA Eksioglu, X Chen, W Kandell, T Le Trinh, L Cen, J Qi, ... Leukemia 33 (8), 2034-2046, 2019 | 76 | 2019 |
| Iron regulator hepcidin exhibits antiviral activity against hepatitis C virus H Liu, TL Trinh, H Dong, R Keith, D Nelson, C Liu Public Library of Science 7 (10), e46631, 2012 | 67 | 2012 |
| Linking metabolism and epigenetic regulation in development of hepatocellular carcinoma WM Puszyk, T Le Trinh, SJ Chapple, C Liu Laboratory investigation 93 (9), 983-990, 2013 | 37 | 2013 |
| Immune evasion by TGFβ-induced miR-183 repression of MICA/B expression in human lung tumor cells TL Trinh, WM Kandell, SS Donatelli, N Tu, MM Tejera, DL Gilvary, ... Oncoimmunology 8 (4), e1557372, 2019 | 35 | 2019 |
| A novel vaccine targeting glypican-3 as a treatment for hepatocellular carcinoma Q Wu, L Pi, T Le Trinh, C Zuo, M Xia, Y Jiao, Z Hou, S Jo, W Puszyk, ... Molecular Therapy 25 (10), 2299-2308, 2017 | 30 | 2017 |
| Functional recovery of natural killer cell activity by nanoparticle‐mediated delivery of transforming growth factor beta 2 small interfering RNA IM Adjei, J Jordan, N Tu, TL Trinh, W Kandell, S Wei, B Sharma Journal of Interdisciplinary Nanomedicine 4 (4), 98-112, 2019 | 17 | 2019 |
| MicroRNA-155 governs SHIP-1 expression and localization in NK cells and regulates subsequent infiltration into murine AT3 mammary carcinoma WM Kandell, SS Donatelli, TL Trinh, AR Calescibetta, T So, N Tu, ... PLoS One 15 (2), e0225820, 2020 | 15 | 2020 |
| Oxidized mitochondrial DNA engages TLR9 to activate the NLRP3 inflammasome in myelodysplastic syndromes GA Ward, RP Dalton III, BS Meyer, AF McLemore, AL Aldrich, NB Lam, ... International Journal of Molecular Sciences 24 (4), 3896, 2023 | 9 | 2023 |
| Neuronal NTPDase3 mediates extracellular ATP degradation in trigeminal nociceptive pathway L Ma, T Trinh, Y Ren, RT Dirksen, X Liu PLoS One 11 (10), e0164028, 2016 | 9 | 2016 |
| CX3CR1 deficiency-induced TIL tumor restriction as a novel addition for CAR-T design in solid malignancies TL Trinh, WA Adams, A Calescibetta, N Tu, R Dalton, T So, M Wei, G Ward, ... Iscience 26 (4), 2023 | 8 | 2023 |
| Isolation of phage‐display library‐derived scFv antibody specific to Listeria monocytogenes by a novel immobilized method XH Nguyen, TL Trinh, TBH Vu, QH Le, KA To Journal of Applied Microbiology 124 (2), 591-597, 2018 | 7 | 2018 |
| Constitutively activated DAP12 induces functional anti-tumor activation and maturation of human monocyte-derived DC R Dalton, A Calescibetta, JM Zhou, M Maurin, G Ward, TL Trinh, N Tu, ... International Journal of Molecular Sciences 22 (3), 1241, 2021 | 6 | 2021 |
| Chemotherapeutic sensitivity of myeloid-derived suppressor cells during cancer therapy is dictated by selective expression of clusterin N Tu, TL Trinh, JM Zhou, DL Gilvary, D Coppola, S Wei, JY Djeu Cancer Research 77 (13_Supplement), 3666-3666, 2017 | 5 | 2017 |
| GPC3-specific chimeric antigen receptor T cell in combination with Sorafenib as a novel therapeutic treatment for hepatocellular carcinoma TL Trinh, Q Wu, LJ Chang, M Ho, C Liu Cancer Research 76 (14_Supplement), 2316-2316, 2016 | 5 | 2016 |
| Epigenetic regulation of glypican-3 in hepatocellular carcinoma TL Trinh, W Puszyk, C Liu Cancer Research 74 (19_Supplement), 418-418, 2014 | 3 | 2014 |
| GPC3-specific chimeric antigen receptor T cell in combination with Sorafenib as a novel therapeutic treatment for hepatocellular carcinoma T Le Trinh, Q Wu, LJ Chang, M Ho, C Liu Cancer Research 76, 2016 | 2 | 2016 |
| S100A9 Contributes to T Cell Dysfunction through Its Interaction with RAGE in MDS W Kandell, T Le Trinh, X Chen, P Cheng, D Gilvary, YK Chen, ... Blood 134, 4228, 2019 | 1 | 2019 |
Erika EksiogluH. Lee Moffitt Cancer Center在 moffitt.org 的电子邮件经过验证
